Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathology in sarcomas.

E de Alava1

  • 1Laboratory of Molecular Pathology, Centro de Investigación del Cáncer-IBMCC, Universidad de Salamanca-CSIC, Salamanca, Spain. edealava@usal.es

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|April 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2022
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

ESMO open·2021
Same author

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same journal

Concordance between multidisciplinary tumor board decisions and AI-based recommendations in endometrial cancer: impact of discordance direction on clinical outcomes.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

External validation of a nomogram for de novo bone metastasis in breast cancer: a single-center Mexican cohort.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Clinical and pathologic insights into early and late breast cancer relapses: a real-world analysis from the El Álamo IV registry.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Neoadjuvant metformin on clinical and pathological response in non-diabetic patients with non-metastatic breast cancer: an updated systematic review and meta-analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Comparative effectiveness of two alternative dosing strategies of pembrolizumab in metastatic non-small-cell lung cancer in a real-world setting.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
See all related articles

Bone and soft tissue sarcomas are rare cancers. This review explores their diverse molecular alterations, aiding pathologists in translational research and clinical applications for these complex tumors.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genetics

Background:

  • Bone and soft tissue sarcomas are rare, with a prevalence of 4 in 100,000 people annually.
  • Histological diversity leads to over a hundred sarcoma types, complicating clinical trials.
  • Sarcomas are molecularly classified into those with specific genetic alterations and those with complex karyotypes.

Purpose of the Study:

  • To review diverse molecular alterations in sarcomas.
  • To discuss the clinical utility of these molecular findings.
  • To highlight implications for pathologists in translational sarcoma research.

Main Methods:

  • Review of existing literature on sarcoma molecular pathology.
  • Analysis of genetic alterations, including translocations and mutations.

Related Experiment Videos

  • Examination of karyotypic complexity and chromosomal gains/losses.

    • Main Results:

    • Sarcomas exhibit two main molecular profiles: specific genetic alterations (e.g., gene fusions, mutations) or unspecific alterations with complex karyotypes.
    • Specific genetic alterations are characteristic of certain sarcoma subtypes.
    • Complex karyotypes with numerous chromosomal aberrations are observed in other sarcoma types.

    Conclusions:

    • Understanding molecular alterations is crucial for sarcoma classification and treatment.
    • Molecular profiling offers utility in clinical diagnosis and therapeutic strategies.
    • Pathologists play a key role in advancing translational research through molecular analysis of sarcomas.